Gilead drug cloning begins at Dr. Reddy’s Laboratories
1 min read
Dr. Reddy’s Laboratories has initiated the process of producing a universal copy of remdesivir, which is an experimental drug advanced by Gilead. It claims to have upgraded the condition of COVID-19 patients in a worldwide probation.
Remdesivir, the antivirus, was previously developed to cure Ebola, but failed. But in a charitable drug event sponsored by Gilead resulted in improvement of 36 severely COVID-19 infected patients among 53.
